Dermata Therapeutics, Inc.
DRMA
$1.16
-$0.0201-1.70%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -7.35% | -41.37% | -46.00% | 19.18% | -17.79% |
Total Receivables | -- | -- | -- | -33.33% | -99.22% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -14.62% | -29.79% | -21.02% | -26.27% | -31.23% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -76.38% | 116.34% | 24.20% | -1.51% | -- |
Total Current Assets | -8.69% | -39.90% | -44.27% | 14.89% | -18.40% |
|
|||||
Total Current Assets | -8.69% | -39.90% | -44.27% | 14.89% | -18.40% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -8.69% | -39.90% | -44.27% | 14.89% | -18.40% |
|
|||||
Total Accounts Payable | 82.00% | 203.15% | 66.87% | 74.35% | -1.90% |
Total Accrued Expenses | 144.69% | 141.21% | -23.10% | 77.88% | -56.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 112.27% | 180.92% | 13.65% | 75.98% | -39.05% |
|
|||||
Total Current Liabilities | 112.27% | 180.92% | 13.65% | 75.98% | -39.05% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 112.27% | 180.92% | 13.65% | 75.98% | -39.05% |
|
|||||
Common Stock & APIC | 16.66% | 8.87% | 7.88% | 15.75% | 12.19% |
Retained Earnings | -21.99% | -19.82% | -18.16% | -17.10% | -16.69% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -26.00% | -58.68% | -52.92% | 5.53% | -14.24% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -26.00% | -58.68% | -52.92% | 5.53% | -14.24% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -26.00% | -58.68% | -52.92% | 5.53% | -14.24% |
|